Skip to content

Trauma Intervention for Affect Regulation, AIDS, and Substances

Trauma Intervention for Affect Regulation, AIDS, and Substances

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02923141
Acronym
TIARAS
Enrollment
16
Registered
2016-10-04
Start date
2017-01-31
Completion date
2018-07-31
Last updated
2018-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus, Post Traumatic Stress Disorder, Substance Related Disorder

Keywords

substance use, trauma, HIV, viral load, women

Brief summary

The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.

Interventions

BEHAVIORALNeutral Writing
BEHAVIORALExpressive Writing
BEHAVIORALContingency Management

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV positive * woman or trans woman * substance use * elevated PTSD symptoms * HIV care difficulties

Exclusion criteria

* not HIV positive * no substance use * men * no HIV care difficulties * no history of trauma

Design outcomes

Primary

MeasureTime frame
Reduction in HIV RNA Copies/mL6 months

Secondary

MeasureTime frameDescription
Increase in T-helper (CD4+) cell count6 months
Reduction in HIV transmission risk6 monthsself-reported condomless, serodiscordant sex and HIV viral load greater than 200 copies/mL
Decrease in stimulant use6 monthsself-report
Decrease in post-traumatic stress disorder (PTSD) symptoms6 monthsself-report measure: PTSD Checklist for DSM-5
Decrease in depressive symptoms6 monthsself-report measure: Centers for the Epidemiologic Study of Depression (CES-D)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026